173 related articles for article (PubMed ID: 28763306)
1. Efficacy and Safety of Proton Pump Inhibitors in the Long-Term Aspirin Users: A Meta-Analysis of Randomized Controlled Trials.
Dahal K; Sharma SP; Kaur J; Anderson BJ; Singh G
Am J Ther; 2017; 24(5):e559-e569. PubMed ID: 28763306
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
[TBL] [Abstract][Full Text] [Related]
3. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
4. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
5. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
Scally B; Emberson JR; Spata E; Reith C; Davies K; Halls H; Holland L; Wilson K; Bhala N; Hawkey C; Hochberg M; Hunt R; Laine L; Lanas A; Patrono C; Baigent C
Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):231-241. PubMed ID: 29475806
[TBL] [Abstract][Full Text] [Related]
6. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.
Yeomans N; Lanas A; Labenz J; van Zanten SV; van Rensburg C; Rácz I; Tchernev K; Karamanolis D; Roda E; Hawkey C; Nauclér E; Svedberg LE
Am J Gastroenterol; 2008 Oct; 103(10):2465-73. PubMed ID: 18637091
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular events associated with proton pump inhibitors.
Jawaid H; Hussain A; Imtiaz F
J Pak Med Assoc; 2017 Sep; 67(9):1466. PubMed ID: 28924299
[No Abstract] [Full Text] [Related]
9. Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleeding.
Yang SC; Wu CK; Tai WC; Liang CM; Yao CC; Wu KL; Hsu CN; Chuah SK
J Gastroenterol Hepatol; 2021 Jul; 36(7):1828-1835. PubMed ID: 33247982
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Proton Pump Inhibitor Co-Therapy in Patients Taking Aspirin for Secondary Prevention of Ischemic Stroke.
Takabayashi N; Murata K; Tanaka S; Kawakami K
Pharmacoeconomics; 2015 Oct; 33(10):1091-100. PubMed ID: 25995130
[TBL] [Abstract][Full Text] [Related]
11. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
[TBL] [Abstract][Full Text] [Related]
12. Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort study.
Chen WC; Li YD; Chiang PH; Tsay FW; Chan HH; Tsai WL; Tsai TJ; Wang EM; Cheng JS; Lai KH
Biomed Res Int; 2014; 2014():693567. PubMed ID: 25295267
[TBL] [Abstract][Full Text] [Related]
13. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Hsu PI
J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
[TBL] [Abstract][Full Text] [Related]
14. [Bleeding ulcers: prevention of relapse: continuous PPI use no better than intermittent].
Escher M
Dtsch Med Wochenschr; 2015 Jan; 140(1):14. PubMed ID: 25580963
[No Abstract] [Full Text] [Related]
15. Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.
Hedberg J; Sundström J; Thuresson M; Aarskog P; Oldgren J; Bodegard J
J Intern Med; 2013 Oct; 274(4):371-80. PubMed ID: 23800296
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk.
Goldstein JL; Whellan DJ; Scheiman JM; Cryer BL; Eisen GM; Lanas A; Fort JG
Cardiovasc Ther; 2016 Apr; 34(2):59-66. PubMed ID: 26725920
[TBL] [Abstract][Full Text] [Related]
17. Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.
Sanuki T; Fujita T; Kutsumi H; Hayakumo T; Yoshida S; Inokuchi H; Murakami M; Matsubara Y; Kuwayama H; Kawai T; Miyaji H; Fujisawa T; Terao S; Yamazaki Y; Azuma T;
J Gastroenterol; 2012 Nov; 47(11):1186-97. PubMed ID: 22526273
[TBL] [Abstract][Full Text] [Related]
18. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of aspirin--and NSAID-induced peptic ulcers].
Satoh K; Tanabe H; Ichiishi E; Ando K
Nihon Rinsho; 2015 Jul; 73(7):1110-5. PubMed ID: 26165066
[TBL] [Abstract][Full Text] [Related]
20. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]